Css LLC Acadia Pharmaceuticals Inc Transaction History

Css LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$20.94 - $27.5 $108,888 - $143,000	-5,200 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $26,897 - $43,398	-1,602 Reduced 23.55%	5,200 $121,000
Q3 2021 Nov 15, 2021	SELL	$15.78 - $24.77 $42,179 - $66,210	-2,673 Reduced 28.21%	6,802 $113,000
Q2 2021 Aug 16, 2021	SELL	$19.4 - $27.42 $189,363 - $267,646	-9,761 Reduced 50.74%	9,475 $231,000
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $481,284 - $1.06 Million	19,236 New	19,236 $496,000

288

161M

723K

257K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.39B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.